Skip to main content
HURNHuron Consulting Group Inc.Sell6.1·$96.80+0.28%
HURN · Concentration risk · 10-K extracted

Huron Consulting Group (HURN) concentration risks

Updated

The most significant concentration Huron Consulting Group discloses is Healthcare segment at 50%, classified MEDIUM by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: Huron Consulting Group’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 2 disclosed concentrations

HIGH0
MEDIUM1
LOW1
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

MEDIUMBuilt-inProduct / Revenue mix
50%

Healthcare segment

10-K Item 1: 'we derived 50%, 30% and 20% of our consolidated revenues before reimbursable expenses from our Healthcare, Education and Commercial operating segments, respectively'
SEC 10-K · filed Feb 2026
LOWOutside partyCustomer
19%

top-10 clients

10-K Item 1: 'our 10 largest clients accounted for approximately 19% of our consolidated revenues'
SEC 10-K · filed Feb 2026
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-06-24

The company's concentration profile is primarily a product-mix exposure, with a limited customer-side dependency. The Healthcare segment contributed 50% of consolidated revenues before reimbursable expenses in the most recent period, alongside Education at 30% and Commercial at 20% of consolidated revenues before reimbursable expenses — making Healthcare the single largest segment by a material margin. By disclosed size this is a medium-share structural concentration; results are meaningfully linked to the financial health, regulatory environment, and transformation spending appetite of health system and hospital clients. The structural character of the segment concentration means the risk is broad rather than idiosyncratic: cuts to hospital capital budgets, changes in healthcare reimbursement policy, or a cyclical slowdown in health system advisory demand would affect the Healthcare segment as a whole rather than depending on any single client's decisions. On the customer side, the 10 largest clients accounted for approximately 19% of consolidated revenues — a low-share dependency that confirms the company's revenue base is not materially dependent on any small cluster of accounts at the top of the client list. The combination of a medium-share segment concentration and a low-share top-client exposure suggests the primary risk lies in the sector rather than in individual client relationships. There are no disclosed geographic or supplier concentrations alongside these exposures.

For the engine’s reasoning on HURN’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Consulting Services

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
BAHBooz Allen Hamilton Holding Cor1023
VRSKVerisk Analytics, Inc.1001
HURNHuron Consulting Group Inc.0112
EFXEquifax, Inc.0011
FCNFTI Consulting, Inc.0000

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks HURN Concentration risk